NEW YORK, Jan. 9 (GenomeWeb News) - Axxam will provide the National Institutes of Health with assays to be used in screening campaigns within the Molecular Libraries Roadmap Initiative, the company said today.
The screening assays were developed and optimized at Axxam for ultra high-throughput screening applications using ultra sensitive signal-detection methods.
The selection would be available to the NIH Chemical Genomics Center.
Financial details were not disclosed.